We are live on
!
Find out more
BCA
Benchmark Capital Advisors Portfolio holdings
AUM
$101M
1-Year Est. Return
0.8%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$127M
AUM Growth
+$153K
(+0.12%)
Cap. Flow
+$1.75M
Cap. Flow
% of AUM
1.38%
Top 10 Holdings %
Top 10 Hldgs %
30.97%
Holding
147
New
23
Increased
40
Reduced
44
Closed
7
Avg Time Held Equity + Options
9.5
quarters
Top 10 Avg Time Held Equity + Options
5.8
quarters
Top 20 Avg Time Held Equity + Options
7.5
quarters
Avg Time Held Equity only
9.5
quarters
Top 10 Avg Time Held Equity only
5.8
quarters
Top 20 Avg Time Held Equity only
7.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$1.96M |
| 2 |
Novartis
NVS
|
+$1.31M |
| 3 |
Cisco
CSCO
|
+$743K |
| 4 |
AbbVie
ABBV
|
+$729K |
| 5 |
Johnson Controls International
JCI
|
+$611K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVA
Covanta Holding Corporation
CVA
|
+$1.98M |
| 2 |
AERI
Aerie Pharmaceuticals
AERI
|
+$1.67M |
| 3 |
Apple
AAPL
|
+$1.07M |
| 4 |
Terex
TEX
|
+$870K |
| 5 |
Citigroup
C
|
+$718K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.14% |
| 2 | Healthcare | 16.68% |
| 3 | Real Estate | 16.39% |
| 4 | Technology | 12.22% |
| 5 | Financials | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Devon Energy
DVN
$55.2B
| $1.41M | 1.11% |
44,053
+14,500
| +49% | +$530K |
2013 Q2
16 quarters
|
|
|
27
Novartis
NVS
$271B
| $1.39M | 1.09% |
+18,526
| New | +$1.31M |
2017 Q2
0 quarters
|
|
28
Viasat
VSAT
$9.22B
| $1.38M | 1.09% |
20,850
+250
| +1% | +$16.4K |
2017 Q1
1 quarter
|
|
29
SRH Total Return Fund
STEW
$1.71B
| $1.36M | 1.08% |
140,500
-1,000
| -0.7% | -$9.47K |
2016 Q4
2 quarters
|
|
30
DELISTED
Volt Information Sciences, Inc.
VOLT
| $1.35M | 1.07% |
342,892
-3,048
| -0.9% | -$16.9K |
2014 Q3
11 quarters
|
|
31
CHS Inc 8% Preferred Stock
CHSCP
$317M
| $1.33M | 1.05% |
43,357
-500
| -1% | -$15.3K |
2013 Q2
16 quarters
|
|
32
BlackRock Core Bond Trust
BHK
$594M
| $1.24M | 0.98% |
89,054
+3,000
| +3% | +$41.1K |
2014 Q4
10 quarters
|
|
33
Procter & Gamble
PG
$355B
| $1.2M | 0.95% |
13,750
+400
| +3% | +$35.3K |
2016 Q2
4 quarters
|
|
34
Abundia Global Impact Group
AGIG
$39.6M
| $1.19M | 0.94% |
12,660
+32
| +0.3% | +$1.86K |
2013 Q2
16 quarters
|
|
35
iShares Europe ETF
IEV
$1.58B
| $1.17M | 0.93% |
26,495
+6,425
| +32% | +$283K |
2017 Q1
1 quarter
|
|
36
Merck
MRK
$350B
| $1.15M | 0.91% |
18,864
-210
| -1% | -$12.8K |
2013 Q2
16 quarters
|
|
37
iShares Mortgage Real Estate ETF
REM
$452M
| $1.14M | 0.9% |
24,637
-1,450
| -6% | -$67.4K |
2013 Q2
16 quarters
|
|
38
AT&T
T
$157B
| $1.12M | 0.88% |
39,210
+5,247
| +15% | +$155K |
2015 Q2
8 quarters
|
|
39
Goldman Sachs Group Inc Depositary Shares
GS.PRA
$577M
| $1.1M | 0.87% |
45,769
-300
| -0.7% | -$7.14K |
2013 Q2
16 quarters
|
|
40
GE Aerospace
GE
$319B
| $1.06M | 0.84% |
8,221
+1,095
| +15% | +$150K |
2013 Q2
16 quarters
|
|
41
Teva Pharmaceutical Industries Limited
TEVA
$48.1B
| $1.06M | 0.84% |
31,944
-300
| -0.9% | -$9.29K |
2016 Q1
5 quarters
|
|
42
Healthpeak Properties
DOC
$13.1B
| $960K | 0.76% |
30,050
+500
| +2% | +$15.8K |
2013 Q2
16 quarters
|
|
43
Amgen
AMGN
$223B
| $861K | 0.68% |
5,000
| – | – |
2015 Q4
6 quarters
|
|
44
Omega Healthcare
OHI
$13.7B
| $815K | 0.64% |
24,675
+1,900
| +8% | +$62.9K |
2016 Q3
3 quarters
|
|
|
45
AbbVie
ABBV
$485B
| $787K | 0.62% |
+10,850
| New | +$729K |
2017 Q2
0 quarters
|
|
|
46
Cisco
CSCO
$454B
| $714K | 0.56% |
+22,800
| New | +$743K |
2017 Q2
0 quarters
|
|
47
DELISTED
Nuveen Dow 30SM Dynamic Overwrite Fund
DIAX
| $705K | 0.56% |
42,693
+6,328
| +17% | +$102K |
2014 Q4
10 quarters
|
|
|
AERI
48
DELISTED
Aerie Pharmaceuticals
AERI
| $704K | 0.56% |
13,400
-35,925
| -73% | -$1.67M |
2014 Q3
11 quarters
|
|
49
Safehold
SAFE
$848M
| $698K | 0.55% |
11,905
-247
| -2% | -$14.6K |
2013 Q2
16 quarters
|
|
|
SSW.PRD
50
DELISTED
Seaspan Corporation 7.95% Series D Cumulative Redeemable Perpetual Preferred Shares
SSW.PRD
| $660K | 0.52% |
30,850
+1,300
| +4% | +$28.4K |
2013 Q2
16 quarters
|
|
Similar funds
OIMU
7A
JCP
DCM
BCEM
QAM
CFA
BPV
Benchmark Capital Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, Benchmark Capital Advisors held 147 positions worth $127M, up 0.12% from $127M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Benchmark Capital Advisors's Q2 2017 filing shows 23 new, 40 increased, 44 reduced and 7 closed positions. Its largest new stake was WisdomTree Japan Hedged Equity Fund: 114,690 shares worth $1.99M. The largest sale was Covanta Holding Corporation, an estimated $1.98M.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Real Estate.
- Benchmark Capital Advisors's largest Q2 2017 buy was WisdomTree Japan Hedged Equity Fund: 114,690 shares worth $1.99M.
- Benchmark Capital Advisors added most to Devon Energy in Q2 2017, an estimated $530K increase.
- Benchmark Capital Advisors's biggest Q2 2017 reduction was Aerie Pharmaceuticals, cutting an estimated $1.67M.
- Benchmark Capital Advisors fully exited Covanta Holding Corporation in Q2 2017, selling an estimated $1.98M.
- Benchmark Capital Advisors's ten largest holdings make up 31% of its $127M portfolio in Q2 2017.
- Benchmark Capital Advisors opened 23 new positions and closed 7 in Q2 2017.
- Benchmark Capital Advisors's portfolio value rose 0.12% quarter-over-quarter to $127M.
Based on Benchmark Capital Advisors's 13F filing for Q2 2017, filed 9 Aug 2017.